The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115205 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Pavla Sustova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, St. Olav's Hospital, Trondheim University Hospital, 7006 Trondheim, Norway. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Papillomaviridae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Western Norway Regional Health Authority.
Abstract (Originalsprache)
Cervical intraepithelial neoplasia (CIN) is caused by human papillomavirus (HPV); however, factors such as HPV genotype and individual immune response may also contribute to its development. The loop electrosurgical excision procedure (LEEP) is a treatment for high-grade cervical intraepithelial neoplasia (CIN), as approximately 30% of these cases may progress to cancer. However, 20–40% of cases will regress spontaneously. HPV16 infection constitutes the highest risk for progression to cervical cancer and a lower probability of regression. Knowledge regarding the regression of lesions caused by other high-risk genotypes alone or in association with biomarker expression and lesion length has been limited. In the present study, the regression rates of high-grade squamous intraepithelial lesions were calculated. Twenty-one percent of the 161 women diagnosed with CIN2-3 on colposcopy-directed biopsies exhibited regression (defined as CIN1 or less) in the subsequent cone excisions. The mean interval between biopsy and treatment was 113 days (range of 71–171). High-grade lesions of the squamous epithelium caused by HPV16, together with lesions caused by HPV31, 52 and 58, showed significantly lower regression rates (HR 0.54, 0.22–0.75; low-regression group) than lesions caused by HPV18, 33, 35, 39, and 45 (HR 2.85, 1.54–5.28; high-regression group). A multivariate analysis of HPV genotypes, epithelial expressions of pRb and p53, immune cell proportions in the stroma (CD4/CD25 and CD4/CD8), and lesion lengths correctly predicted regression in 78% (Harrell’s C). A Harrell’s C value of 82% for the low-regression group indicates that different HPV genotypes or groups, together with divergent patterns of tumor suppressors, immune cells, and lesion size, can give prognostic information regarding the outcome of CIN2-3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, St. Olav's Hospital, Trondheim University Hospital, 7006 Trondheim, Norway.
- Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, 7030 Trondheim, Norway.
- Department of Cervical Cancer Screening, Cancer Registry of Norway, Norwegian Institute of Public Health, 0304 Oslo, Norway.
- Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
- Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, 0424 Oslo, Norway.
- Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, 0304 Oslo, Norway.
ORCID-Profile: Birgit Engesæter, Jan P A Baak, Emiel A M Janssen
Förderung
- Western Norway Regional Health Authority
Zitieren
APA
Sustova, P., Engesæter, B., Øvestad, I. T., Gudlaugsson, E. G., Ghiasvand, R., Skaland, I., Baak, J. P. A., Tropé, A., Janssen, E. A. M., & Munk, A. C. (2025). The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115205
Vancouver
Sustova P, Engesæter B, Øvestad IT, Gudlaugsson EG, Ghiasvand R, Skaland I, et al. The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115205
BibTeX
@article{Sustova2025,
author = {Sustova, Pavla and Engesæter, Birgit and Øvestad, Irene Tveiterås and Gudlaugsson, Einar G and Ghiasvand, Reza and Skaland, Ivar and Baak, Jan P A and Tropé, Ameli and Janssen, Emiel A M and Munk, Ane Cecilie},
title = {The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115205}
}
EUVIMED